Eli Lilly has petitioned the Supreme Court to reconsider a lower court decision invalidating a patent on Cialis, calling the case "a particularly egregious example of functional claiming." Lilly argues German company Erfindergemeinschaft UroPep "drafted a single-step claim using purely functional language to assert ownership over the use of a huge universe of compounds, including the active ingredient in a commercially successful product already on the market."
Sign up for FDLI SmartBrief
News for the food and drug law community
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.